Semaglutide
Semaglutide is an FDA approved injectable glucagon-like peptide-1 (GLP-1) that’s administered once weekly for weight loss. Semaglutide is actually a peptide (small chain of amino acids) that activates Glucagon-Like-Peptide 1 (GLP-1) receptor increasing insulin secretion, decreasing glucagon secretion and delaying stomach emptying. The average person losses 2-4 pounds a week with this cutting-edge option.